Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Joint Corp. stock logo
JYNT
Joint
$7.04
-1.1%
$8.16
$6.98
▼
$10.67
$100.70M1.09100,705 shs43,483 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$2.63
-0.8%
$3.17
$2.56
▼
$6.68
$127.73M1.99822,441 shs620,106 shs
PARK
Park Dental Partners
$20.25
-1.7%
$20.75
$9.53
▼
$26.79
$97.96MN/A25,787 shs4,597 shs
Precipio, Inc. stock logo
PRPO
Precipio
$23.12
-0.3%
$25.63
$16.40
▼
$33.63
$41.51M1.388,114 shs22,201 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Joint Corp. stock logo
JYNT
Joint
-1.12%-3.30%-12.98%-21.69%-19.82%
LifeMD, Inc. stock logo
LFMD
LifeMD
-0.75%-4.01%-10.85%-43.32%-60.39%
PARK
Park Dental Partners
-1.70%+2.07%-3.48%-3.25%+2,024,999,900.00%
Precipio, Inc. stock logo
PRPO
Precipio
-0.30%-0.04%-9.69%-2.86%+25.99%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Joint Corp. stock logo
JYNT
Joint
$7.04
-1.1%
$8.16
$6.98
▼
$10.67
$100.70M1.09100,705 shs43,483 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$2.63
-0.8%
$3.17
$2.56
▼
$6.68
$127.73M1.99822,441 shs620,106 shs
PARK
Park Dental Partners
$20.25
-1.7%
$20.75
$9.53
▼
$26.79
$97.96MN/A25,787 shs4,597 shs
Precipio, Inc. stock logo
PRPO
Precipio
$23.12
-0.3%
$25.63
$16.40
▼
$33.63
$41.51M1.388,114 shs22,201 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Joint Corp. stock logo
JYNT
Joint
-1.12%-3.30%-12.98%-21.69%-19.82%
LifeMD, Inc. stock logo
LFMD
LifeMD
-0.75%-4.01%-10.85%-43.32%-60.39%
PARK
Park Dental Partners
-1.70%+2.07%-3.48%-3.25%+2,024,999,900.00%
Precipio, Inc. stock logo
PRPO
Precipio
-0.30%-0.04%-9.69%-2.86%+25.99%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Joint Corp. stock logo
JYNT
Joint
1.67
ReduceN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
2.70
Moderate Buy$7.57187.89% Upside
PARK
Park Dental Partners
2.50
Moderate Buy$28.5040.74% Upside
Precipio, Inc. stock logo
PRPO
Precipio
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest PRPO, LFMD, JYNT, and PARK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/17/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingBuy$9.00
9/16/2026
The Joint Corp. stock logo
JYNT
Joint
DowngradeHold (C-) ➝ Sell (D+)
9/11/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Initiated CoverageBuy$8.00
9/1/2026
The Joint Corp. stock logo
JYNT
Joint
UpgradeSell (D+) ➝ Hold (C-)
9/1/2026
PARK
Park Dental Partners
UpgradeSell (E+) ➝ Sell (D-)
8/17/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
UpgradeStrong Sell ➝ Hold
8/14/2026
PARK
Park Dental Partners
Reiterated RatingBuy$30.00
8/13/2026
The Joint Corp. stock logo
JYNT
Joint
DowngradeHold (C-) ➝ Sell (D+)
8/13/2026
PARK
Park Dental Partners
Set Price Target$27.00
8/7/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Set Price TargetOverweight$5.00
8/7/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Lower Price TargetBuy$10.00 ➝ $9.00
(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Joint Corp. stock logo
JYNT
Joint
$54.90M1.81$0.10 per share73.20$1.01 per share6.97
LifeMD, Inc. stock logo
LFMD
LifeMD
$194.05M0.65N/AN/A$0.48 per share5.48
PARK
Park Dental Partners
$244.49M0.39$4.32 per share4.69$5.33 per share3.80
Precipio, Inc. stock logo
PRPO
Precipio
$24.05M1.72$0.79 per share29.19$8.31 per share2.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Joint Corp. stock logo
JYNT
Joint
$2.91M$0.2726.0710.51N/A6.49%12.02%3.47%11/5/2026 (Estimated)
LifeMD, Inc. stock logo
LFMD
LifeMD
$14.35M-$0.05N/AN/AN/A0.10%-168.23%-31.27%11/11/2026 (Estimated)
PARK
Park Dental Partners
-$360K$1.0519.2919.66N/AN/AN/AN/AN/A
Precipio, Inc. stock logo
PRPO
Precipio
-$360K-$0.64N/AN/AN/A-4.47%-8.49%-5.75%11/16/2026 (Estimated)

Latest PRPO, LFMD, JYNT, and PARK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
The Joint Corp. stock logo
JYNT
Joint
$0.11N/AN/AN/A$14.85 millionN/A
8/14/2026Q2 2026
Precipio, Inc. stock logo
PRPO
Precipio
-$2.00-$0.12+$1.88-$0.12$1.68 million$7.02 million
8/12/2026Q2 2026
PARK
Park Dental Partners
$0.04$0.66+$0.62$0.22N/A$66.21 million
8/6/2026Q2 2026
The Joint Corp. stock logo
JYNT
Joint
$0.0467$0.05+$0.0033$0.05$14.57 million$15.18 million
8/5/2026Q2 2026
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.1457-$0.16-$0.0143-$0.16$49.16 million$47.28 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
The Joint Corp. stock logo
JYNT
Joint
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
PARK
Park Dental Partners
N/AN/AN/AN/AN/A
Precipio, Inc. stock logo
PRPO
Precipio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Joint Corp. stock logo
JYNT
Joint
N/A
1.83
1.83
LifeMD, Inc. stock logo
LFMD
LifeMD
N/A
0.90
0.84
PARK
Park Dental Partners
0.31
1.12
1.12
Precipio, Inc. stock logo
PRPO
Precipio
0.06
1.77
1.56

Institutional Ownership

CompanyInstitutional Ownership
The Joint Corp. stock logo
JYNT
Joint
76.88%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
PARK
Park Dental Partners
N/A
Precipio, Inc. stock logo
PRPO
Precipio
10.45%

Insider Ownership

CompanyInsider Ownership
The Joint Corp. stock logo
JYNT
Joint
30.20%
LifeMD, Inc. stock logo
LFMD
LifeMD
17.22%
PARK
Park Dental Partners
10.56%
Precipio, Inc. stock logo
PRPO
Precipio
16.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Joint Corp. stock logo
JYNT
Joint
33014.14 million9.87 millionOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
38448.20 million39.90 millionOptionable
PARK
Park Dental Partners
1,2124.76 million4.25 millionN/A
Precipio, Inc. stock logo
PRPO
Precipio
711.79 million1.49 millionNo Data

Recent News About These Companies

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
Precipio Announces Q2-2026 Financial Results
Precipio Announces Q2-2026 Shareholder Update Call
Precipio Inc.
Precipio to Present at the Planet MicroCap Las Vegas

New MarketBeat Followers Over Time

Media Sentiment Over Time

Joint stock logo

Joint NASDAQ:JYNT

$7.04 -0.08 (-1.12%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$7.02 -0.02 (-0.28%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$2.63 -0.02 (-0.75%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$2.64 +0.01 (+0.38%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Park Dental Partners NASDAQ:PARK

$20.24 -0.37 (-1.77%)
As of 10/9/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

As a dental resource organization (“DRO”) operating through Park Dental Partners, Inc., and subsidiaries, we provide comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to our affiliated general and multi-specialty dental practices (which are not legal subsidiaries) throughout Minnesota and Wisconsin. Our network of affiliated dental practices employs over 200 dentists across 84 practice locations and was ranked as one of Minnesota’s largest private companies by revenue by the Minneapolis/St Paul Business Journal in June 2025. Our clinical support team includes over 900 hygienists, dental assistants, and patient care coordinators that support affiliated dentists in operating their dental practices. Our network of affiliated dental practices has been operating for over fifty years, beginning with the establishment of the general dentistry group in 1972. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today. Our network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30 years, with automatic 5-year renewals. We have established a significant footprint and brand awareness in our current markets. Our revenues, derived primarily from our affiliated dental practices’ provision of dental services, were approximately $183.3 million and $172.9 million for the nine months ended September 30, 2025 and 2024, respectively, and were approximately $229.8 million and $223.5 million for the years ended December 31, 2024 and 2023, respectively. Our material revenues are comprised of dental services, which includes the consolidated revenues of our affiliated dental practices. Dental services are provided to patients, who typically pay for services through private insurance plans, government insurance plans, or directly. Approximately 91% and 93% of total revenues for each of the nine months ended September 30, 2025, and 2024, respectively, and approximately 93% of total revenues for each of the years ended December 31, 2024 and 2023, respectively, were derived from patients with private insurance or government sponsored plans. Dental care patients tend to be price-sensitive because many pay for a significant portion of their dental expenses on an out-of-pocket basis. We have steadily grown by adding new dentists and team members, expanding existing practices, implementing operating efficiencies, and by acquiring existing practices. Our organic expansion includes opening de novo practices, which are new practice locations opened with our affiliated dentists in existing or new markets. Since the start of calendar 2014 we have acquired 40 practices and opened 11 de novo practices. On average, de novo practices are cash flow positive within approximately six months, meaning that the practice location monthly Gross Margin excluding depreciation is positive. Of the 11 de novo practices opened since 2014, more than 80% were cash flow positive within six months. We attribute this success to our established model that streamlines day-to-day dental practice operations by providing key business and administrative resources, allowing dentists and team members to focus on patient care. We plan to expand our existing general and multi-specialty dental brands, establishing a group of successful, respected dental practices. Dentists hold a majority interest in our organization, which we believe is a key differentiator between our model and those of our competitors. Our model provides our affiliated dentists with significant organizational input because our affiliated dentists, who are majority shareholders in the business, are directly involved in our governance through their right to appoint three directors to the Board of Directors. We believe this right helps ensure that our affiliated dentists maintain a professional voice in governance that helps focus the organization on ensuring patients enjoy the benefits of a lifetime of good oral health. We believe this compelling model allows for greater input and provides enhanced stewardship for dentists, which assists with attracting and retaining dental professionals and serves as a catalyst for future growth. By contrast, we believe traditional dental organization ownership structures, many of which are funded by private equity, introduce constraints and concessions that limit dentists’ clinical autonomy and can restrict or omit dentists’ professional voice in governance. --- Our affiliated dental practices have been in operation since the founding of Park Dental in 1972. In May 2023, the owners of our affiliated dental practices established a dental resource organization 100% owned by dentists and management, through the creation of Park Dental Partners, Inc. and transitioned to the new operating structure on October 1, 2023. Park Dental Partners, Inc was incorporated in the state of Minnesota in 2023 to act as a dental resource organization for the operating affiliated dental practices. Our principal executive offices are located in Roseville, Minnesota.

Precipio stock logo

Precipio NASDAQ:PRPO

$23.12 -0.07 (-0.30%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$23.06 -0.06 (-0.26%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.